Category Archives: BioUtah News

Cambridge, MA, November 9, 2022 /Business Wire/ – Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced that Ipsen, SA (“Ipsen”) issued a press release today reporting its primary analysis of the results of its Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) as a […]

Exhibiting their innovative products and services to over 80,000 visitors, 11 life science companies represented Utah at the MEDICA trade show in Düsseldorf, Germany. Looking across the global landscape of innovative healthcare products, Charlotte Serage, WTC Utah’s manager of trade shows and trade missions, said, “It’s clear that Utah is a major player.” Shoutout to EVŌQbio, Matia Mobility, NanoSpot.ai, SINTX […]

SALT LAKE CITY–(BUSINESS WIRE)–Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by chronic inflammation, was invited to present today at the 4th Inflammasome Therapeutics Summit. Dr. David J. Bearss, CEO of Halia Therapeutics, will chair a panel entitled, “Advances in Proof-of-Concept Trials & Moving Towards the Clinic,” and also […]

LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal first quarter ended September 30, 2022. Recent […]

by Julie A. Vetalice Ortho Development BKS Total PSI has been released for commercial distribution in the United States in collaboration with Materialise, a provider of additive manufacturing software and 3D printing solutions. BKS Total PSI is compatible with Ortho Development’s BKS and BKS TriMax total knee replacement systems. BKS Total PSI, powered by Materialise, […]

SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests that cover every stage of prostate cancer care. UroSuite includes Myriad’s Prolaris® Prostate Cancer Test, MyRisk™ Hereditary Cancer Test, […]

On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants. Governor […]